Natixis Advisors, L.P. Embecta Corp. Transaction History
Natixis Advisors, L.P.
- $53.5 Billion
- Q4 2024
A detailed history of Natixis Advisors, L.P. transactions in Embecta Corp. stock. As of the latest transaction made, Natixis Advisors, L.P. holds 33,268 shares of EMBC stock, worth $509,998. This represents 0.0% of its overall portfolio holdings.
Number of Shares
33,268
Previous 30,735
8.24%
Holding current value
$509,998
Previous $433,000
58.66%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding EMBC
# of Institutions
404Shares Held
52.4MCall Options Held
120KPut Options Held
66.8K-
Black Rock Inc. New York, NY9.19MShares$141 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.03MShares$108 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.27MShares$50.1 Million1.68% of portfolio
-
American Century Companies Inc Kansas City, MO3.26MShares$50 Million0.04% of portfolio
-
River Road Asset Management, LLC3.25MShares$49.8 Million0.95% of portfolio
About Embecta Corp.
- Ticker EMBC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 57,836,500
- Market Cap $887M
- Description
- Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...